Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

NCT07177352 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

13000

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimers Disease

Interventions

OTHER: No Intervention

Sponsor

Hoffmann-La Roche